CA1176261A - Hydantoin derivatives - Google Patents

Hydantoin derivatives

Info

Publication number
CA1176261A
CA1176261A CA000280455A CA280455A CA1176261A CA 1176261 A CA1176261 A CA 1176261A CA 000280455 A CA000280455 A CA 000280455A CA 280455 A CA280455 A CA 280455A CA 1176261 A CA1176261 A CA 1176261A
Authority
CA
Canada
Prior art keywords
hydroxy
carbon atoms
formula
compound
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000280455A
Other languages
English (en)
French (fr)
Inventor
Albert G. Caldwell
Norman Whittaker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Application granted granted Critical
Publication of CA1176261A publication Critical patent/CA1176261A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/86—Oxygen and sulfur atoms, e.g. thiohydantoin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA000280455A 1976-06-03 1977-06-02 Hydantoin derivatives Expired CA1176261A (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB22877/76 1976-06-03
GB2287776 1976-06-03
GB5034076 1976-12-02
GB50340/76 1976-12-02
GB12145/77 1977-03-23
GB1214577 1977-03-23

Publications (1)

Publication Number Publication Date
CA1176261A true CA1176261A (en) 1984-10-16

Family

ID=27256793

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000280455A Expired CA1176261A (en) 1976-06-03 1977-06-02 Hydantoin derivatives

Country Status (12)

Country Link
JP (1) JPS52151168A (is)
CA (1) CA1176261A (is)
CH (3) CH645631A5 (is)
DE (1) DE2724948A1 (is)
DK (1) DK244577A (is)
ES (5) ES459412A1 (is)
FI (1) FI71930C (is)
FR (1) FR2362839A1 (is)
HU (1) HU183046B (is)
NL (1) NL7706064A (is)
NZ (1) NZ184281A (is)
SE (2) SE446336B (is)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1602188A (en) * 1977-12-01 1981-11-11 Wellcome Found Hydantoin derivatives
AU527959B2 (en) * 1977-09-05 1983-03-31 Wellcome Foundation Limited, The Hydantoin derivatives
DK543178A (da) * 1977-12-01 1979-06-02 Wellcome Found Thiodydantoinderivater
DE2963795D1 (en) * 1978-01-23 1982-11-11 Beecham Group Plc Hydantoins and thiohydantoins, method for their preparation and pharmaceutical compositions containing them
EP0004723A1 (en) * 1978-03-30 1979-10-17 Beecham Group Plc Deoxyhydantoins, processes for their preparation and pharmaceutical compositions containing them
GB1599740A (en) * 1978-05-31 1981-10-07 Wellcome Found Hydantoin derivatives
AU4778279A (en) * 1978-06-15 1979-12-20 Beecham Group Limited Prostaglandin analogues
IL57504A0 (en) * 1978-06-15 1979-10-31 Beecham Group Ltd Prostagandin analogues,their preparation and pharmaceutical compositions containing
EP0006352A1 (en) * 1978-06-15 1980-01-09 Beecham Group Plc Hydantoins and thiohydantoins, process for their preparation and pharmaceutical compositions containing them
EP0007180B1 (en) * 1978-06-15 1983-03-30 Beecham Group Plc Prostaglandin analogue triazole derivatives, processes for their preparation and a pharmaceutical composition containing them
IL59065A0 (en) * 1979-01-18 1980-05-30 Beecham Group Ltd Hydantoin derivatives,their preparation pharmaceutical compositons containing them
JPS55151569A (en) * 1979-05-09 1980-11-26 Wellcome Found Optically active heterocyclic compounds* their synthesis and medical blend containing them
US4684735A (en) * 1985-07-01 1987-08-04 Stauffer Chemical Company Promotion of raney nickel hydrogenation catalyst
JP3022878U (ja) * 1995-08-18 1996-04-02 有限会社春江加工 ミニディスク用ケース
MXPA04005123A (es) * 2001-11-30 2005-02-17 Lilly Co Eli Agonistas del receptor activado por proliferador de peroxisoma.
CA2528179C (en) * 2003-06-06 2013-10-22 Allergan, Inc. Piperidinyl prostaglandin e analogs
US7179820B2 (en) * 2003-06-06 2007-02-20 Allergan, Inc. Piperidinyl prostaglandin E analogs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1524818A (en) * 1974-11-29 1978-09-13 Beecham Group Ltd 12-azaprostaglandins

Also Published As

Publication number Publication date
ES459412A1 (es) 1978-11-01
FI71930C (fi) 1987-03-09
ES8103057A1 (es) 1981-02-16
ES489883A0 (es) 1981-02-16
CH646426A5 (en) 1984-11-30
NL7706064A (nl) 1977-12-06
HU183046B (en) 1984-04-28
SE7706428L (sv) 1977-12-04
ES470428A1 (es) 1979-09-01
FR2362839B1 (is) 1980-02-01
DK244577A (da) 1977-12-04
DE2724948A1 (de) 1977-12-15
CH645631A5 (en) 1984-10-15
JPS52151168A (en) 1977-12-15
NZ184281A (en) 1980-04-28
SE8203161L (sv) 1982-05-19
FR2362839A1 (fr) 1978-03-24
SE446336B (sv) 1986-09-01
ES478156A1 (es) 1979-11-01
JPS6222986B2 (is) 1987-05-20
FI71930B (fi) 1986-11-28
FI771763A (fi) 1977-12-04
CH647511A5 (en) 1985-01-31
ES482010A1 (es) 1980-08-16

Similar Documents

Publication Publication Date Title
CA1176261A (en) Hydantoin derivatives
EP0002259B1 (en) Hydantoin derivatives and salts thereof, their synthesis and pharmaceutical formulations
US4188403A (en) Cyclopentan-1-amines
US4204068A (en) Nitrogen heterocycles
EP0001238B1 (en) Hydantoin derivatives, their synthesis, pharmaceutical formulations and intermediates in their preparation
US4337262A (en) Hydantoin derivatives, pharmaceutical compounds and methods of use
US4289707A (en) Nitrogen heterocycles
US4608375A (en) Quinazolinone derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
US4341789A (en) Cycloaliphatic prostaglandin analogues
US4298745A (en) Hydantoin derivatives
GB1595694A (en) Hyantoin analogues
US4262008A (en) 2,4-Disubstituted 5-oxo-5H-hexahydrofuro[3,2b]pyrroles
US4136190A (en) 4,4-dimethyl-3,5-pyrrolidinediones
GB1599740A (en) Hydantoin derivatives
US4241074A (en) Prostaglandin analogues
US4262128A (en) Nitrogen heterocycles
US4413002A (en) Bronchodilating hydantoin derivatives
GB1603407A (en) Hydantoin derivatives
US4610999A (en) 4-substituted Δ2-imidazolinyl-thioethers with prostaglandin-like activity
GB2032419A (en) Hydantoin Prostaglandin Analogues
US4611000A (en) 5-substituted Δ2-imidazolinyl-thioethers with prostaglandin-like activity
GB1595695A (en) Hydantoin analogues
US4548936A (en) Δ1 -Pyrroline thiolactim ethers and a process for their preparation
IE45881B1 (en) Hydantoin analogues
EP0046597B1 (en) 2,4-diazabicyclo(3.3.0)octane-3-one derivatives, their preparation and their pharmaceutical formulation

Legal Events

Date Code Title Description
MKEX Expiry